Reverse Transcriptase in Viruses Quiz

Retroviruses utilize reverse transcriptase to convert their RNA genome into DNA.

Zidovudine is an antiretroviral drug that inhibits reverse transcriptase activity.

Hepatitis C virus (HCV) does NOT utilize reverse transcriptase during its replication.

A characteristic feature of reverse transcriptase is that it requires a primer for its activity.

Reverse transcriptase activity in telomerase synthesizes telomeric DNA from an RNA template.

The primary function of reverse transcriptase in retroviruses is the conversion of RNA to DNA.

Reverse transcriptase is responsible for synthesizing a complementary DNA strand from an RNA template.

Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) target the viral enzyme reverse transcriptase.

HIV utilizes reverse transcriptase to convert its viral RNA into DNA during its replication cycle.

The ribonuclease H (RNase H) domain of reverse transcriptase degrades RNA in the RNA-DNA hybrid.

Exonuclease activity is NOT a characteristic of reverse transcriptase.

Reverse transcriptase is significant in molecular biology as it enables the synthesis of cDNA from mRNA for gene expression studies.

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) directly inhibit the reverse transcription step of the viral life cycle.

Reverse transcriptase inhibitors are significant in treating HBV infection by inhibiting the viral DNA polymerase.

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) bind allosterically to the enzyme and induce conformational changes.